Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
194.4 USD | +2.03% | -1.92% | -24.88% |
Apr. 19 | Needham Adjusts Price Target on Biogen to $294 From $300 | MT |
Apr. 19 | BMO Capital Adjusts Price Target on Biogen to $260 From $285, Outperform Rating Kept | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-24.88% | 27.69B | |
-5.99% | 84.46B | |
+2.76% | 40.85B | |
+53.61% | 24.28B | |
-8.08% | 17.09B | |
-33.74% | 13.67B | |
-16.63% | 11.86B | |
-11.19% | 11.79B | |
-2.25% | 8.07B | |
+1.05% | 7.51B |
- Stock Market
- Equities
- BIIB Stock
- News Biogen Inc.
- Wells Fargo Adjusts Biogen's Price Target to $350 From $265, Reiterates Overweight Rating